Laylay, Wilma C.

HRN: 14-39-04  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/09/2025
CEFUROXIME 500MG (TAB)
09/09/2025
09/15/2025
ORAL
500mg
BID
UTI
Remove - Pending Acceptance
09/10/2025
CEFTRIAXONE 1G (VIAL)
09/10/2025
09/17/2025
IV
2g
OD
Uti
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: